DNM1L and early-onset autosomal dominant Alzheimer disease: In addition, ursodeoxycholic acid, a kind of bile acid, has been demonstrated to have potential therapeutic effects in Alzheimer’s disease (AD) by correcting mitochondrial morphology and membrane structure through its impact on dynamin-related protein 1 [60].